Nuvation Bio Inc. (NUVB)

NYSE: NUVB · Real-Time Price · USD

5.74

+0.01 (0.17%)

At close: Sep 25, 2026, 4:00 PM EDT

5.81

+0.07 (1.22%)

After-hours: Sep 25, 2026, 7:38 PM EDT

Nuvation Bio Financials Overview

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	169.9	62.9	7.87	-	-	-
Revenue Growth	1083.56%	698.96%	-	-	-	-
Gross Profit	149.81	53.6	0.8	-	-	-
Operating Income	-137.63	-213.06	-167.56	-99.82	-119.73	-89.53
Net Income	-149.83	-204.63	-567.94	-75.8	-104.2	-86.85
Earnings Per Share	-0.44	-0.60	-2.11	-0.35	-0.48	-0.44
EPS Growth	-	-	-	-	-	-

Revenue by Geography

Fiscal Year	TTM	FY 2025	FY 2024
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
United States	124	24.66	-
China	16.34	9.41	5.15
Japan	29.56	28.83	2.73
Total	169.9	62.9	7.87

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	660.96	529.21	502.69	611.21	661.01	765.39
Total Debt	416.26	66.94	8.92	4.01	4.26	3.06
Net Cash (Debt)	244.69	462.27	493.78	607.21	656.75	762.34
Net Cash Growth	-39.49%	-6.38%	-18.68%	-7.54%	-13.85%	253.34%
Net Cash Per Share	0.72	1.35	1.84	2.77	3.03	3.85

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	-120.52	-173.43	-130.41	-68	-96.11	-68.19
Capital Expenditures	-0.4	-0.35	-0.16	-0.07	-0.37	-0.28
Free Cash Flow	-120.93	-173.78	-130.58	-68.07	-96.48	-68.47
Free Cash Flow Growth	-	-	-	-	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	88.17%	85.22%	10.10%	-	-	-
Operating Margin	-81.00%	-338.72%	-2128.25%	-	-	-
Pretax Margin	-88.19%	-325.31%	-7213.76%	-	-	-
Profit Margin	-88.19%	-325.31%	-7213.76%	-	-	-
FCF Margin	-71.17%	-276.27%	-1658.52%	-	-	-

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 27, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PS Ratio	11.86	48.83	113.71	-	-	-